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Abstract An extensive study of the metabolism of the
type A trichothecene mycotoxins HT-2 toxin and T-2 toxin
in barley using liquid chromatography coupled to high-
resolution mass spectrometry (LC-HRMS) is reported. A
recently developed untargeted approach based on stable
isotopic labelling, LC-Orbitrap-MS analysis with fast po-
larity switching and data processing by MetExtract soft-
ware was combined with targeted LC-Q-TOF-MS(/MS)
analysis for metabolite structure elucidation and quantifica-
tion. In total, 9 HT-2 toxin and 13 T-2 toxin metabolites
plus tentative isomers were detected, which were success-
fully annotated by calculation of elemental formulas and
further LC-HRMS/MS measurements as well as partly
identified with authentic standards. As a result,
glucosylated forms of the toxins, malonylglucosides, and
acetyl and feruloyl conjugates were elucidated. Additional-
ly, time courses of metabolite formation and mass balances
were established. For absolute quantification of those com-
pounds for which standards were available, the method
was validated by determining apparent recovery, signal
suppression, or enhancement and extraction recovery. Most
importantly, T-2 toxin was rapidly metabolised to HT-2
toxin and for both parent toxins HT-2 toxin-3-O-β-gluco-
side was identified (confirmed by authentic standard) as
the main metabolite, which reached its maximum already
1 day after toxin treatment.
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Maskedmycotoxins
Introduction
HT-2 toxin (HT2) and T-2 toxin (T2) are secondary metabo-
lites of fungi belonging to the genus Fusarium and are classi-
fied as type A trichothecene mycotoxins. Small grain cereals,
oats, wheat and barley, are especially affected by type A
trichothecene-producing fungi and consequently are prone to
contamination with HT2 and T2 [1, 2]. The toxins differ struc-
turally in an acetyl group at the C-4 position (see Electronic
SupplementaryMaterial (ESM) Fig. S1) but show similar tox-
i co log ica l e f fec t s such as immunotox ic i ty and
haematotoxicity [3].
Plants employ various detoxification mechanisms to cope
with the adverse effects of mycotoxins. For instance, phase I
metabolism processes (enzymatic hydrolysis, oxidation and
reduction) as well as phase II metabolism processes (covalent
binding of, e.g. glucose, malonic acid, sulphuric acid, amino
acids or glutathione) are used by the affected plants to inacti-
vate xenobiotics [4]. Understanding the plant metabolism of
mycotoxins and thus the resulting metabolic derivatives is
becoming increasingly important for risk assessment. Up to
now, there is no legislation for these so-called masked myco-
toxins in food or feed, although studies [5, 6] have indicated
that they might exhibit similar toxicity when cleaved during
digestion [4]. Only limited knowledge exists about the bio-
transformation process of HT2 and T2 in plants. In an early
article, Mirocha et al. [7] reported the occurrence of HT2,
T-2-tetraol, 3′-hydroxy-HT-2 and 3′-hydroxy-T-2 formed in
T2-treated Baccharis species. A few authors have described
monoglucoside derivatives [2, 8–12] (HT2-Glc and T2-Glc)
and diglucoside derivatives [10, 11] (HT2-di-Glc) to be
formed in planta. Additionally, an extensive study of
the metabolism of HT2 and T2 in wheat was recently
performed in our lab [13]. Whilst the work presented
here details the technical aspects of metabolite detection
and characterisation, the study mentioned above focuses
on the biological interpretation of HT2 and T2 metabo-
lism in wheat and therefore complements the presented
study.
Generally, the global untargeted analysis of endogenous
metabolites and metabolic products of xenobiotics in biolog-
ical systems constitutes a major challenge because of their
chemical and physical diversity [14, 15]. Liquid chromatog-
raphy coupled to high-resolution mass spectrometry (LC-
HRMS) is often used for metabolism studies. To cover as
manymetabolites as possible, it has been shown that measure-
ments in positive and negative polarity should be performed
which is ideally combined in time-saving fast polarity
switching mode [16]. However, untargeted full scan LC-
HRMS measurements produce large datasets which have to
be interpreted properly. To this end, bioinformatic tools are
frequently applied to extract relevant signals from raw data.
Data interpretation with the single use of statistical methods
such as principle components analysis (PCA) is limited to
differential comparison between the tested experimental con-
ditions and is partly error-prone [14]. One way to circumvent
this problem is the employment of isotopic labelling ap-
proaches. Several authors have successfully performedmetab-
olism studies employing stable isotopically labelled tracers
[17–19]. In a further step, software tools to recognise specific
characteristics of labelling in measurement data enable rapid
and automated data evaluation [20, 21]. Bueschl et al. [22, 23]
developed a programme to extract signals of labelled metab-
olites from LC-MS data. This procedure allows a truly
untargeted analysis with the complete removal of unwanted
signals coming from biological matrix, solvents, reagent im-
purities, background and instrument noise.
The objective of this study was to investigate the metabo-
lism of the two major type A trichothecenes HT2 and T2 in
barley. For this purpose, an untargeted method was applied by
combining stable isotopic labelling, LC-Orbitrap-MS analysis
in fast polarity switching mode and MetExtract data process-
ing. After structure annotation, quantification experiments
were performed with a Q-TOF instrument in order to study
the kinetics of the metabolism of parent toxins and their major
biotransformation products. To the best of our knowledge, this
is the first demonstration of an automated fast polarity
switching approach used to study the metabolism of a xeno-
biotic in planta. To cover the set of potential toxin derivatives
as complete as possible, measurements in both polarities were
essential resulting in complementary information, revealing
novel metabolites.
Materials and methods
In general, three main experiments were carried out named
hereafter qualitative screening, structure annotation and time
course experiment (workflow presented in ESM Fig. S2).
Chemicals and standards
Methanol (MeOH) and acetonitrile (ACN) were pur-
chased from VWR (Vienna, Austria). Formic acid (FA)
and Tween 20 were obtained from Sigma-Aldrich
(Vienna, Austria), whilst ammonium formate solution
(5 M, NH4HCO2) was provided by Agilent Technolo-
gies (Waldbronn, Germany). All solvents were LC gra-
dient grade or higher. Purified water (H2O) was pro-
duced by reverse osmosis and an ELGA Purelab Ultra
Mk2 Analytic system from Veolia (Vienna, Austria).
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The following standard compounds (all purities speci-
fied by the supplier) were purchased from Romer Labs
(Tulln, Austria): crystalline non-labelled HT2 (purity
92 %) and T2 toxin (purity 85 %) as well as uniformly
labelled U-13C22 HT2 (purity 86 %; 99.3 atom%
13C)
and U-13C24 T2 (purity 98 %; 99.6 atom%
13C). Barley
test solutions of HT2 and T2 (qualitative screening
experiment) were prepared by mixing non-labelled
and labelled toxins (both 2,000 mg L−1) 1+1 (v/v) to
obtain a concentration of 1,000 mg L−1 per toxin in
ACN/MeOH/H2O 10+45+45 (v/v/v). All biological ma-
terial treated with this mixture is later referred to as
labelled barley samples or 12C/13C samples. Time course
experiments were performed with a test solution of non-
labelled HT2 and T2 toxin with 1,000 mg L−1 in
ACN/H2O 1+1 (v/v)+1 % Tween 20. Respective sam-
ples are later referred to as non-labelled or 12C samples.
For each experiment, test solutions solely containing the
corresponding solvent mixtures (mock) were prepared to
obtain blank samples. Analytical standards of HT2 and
T2 toxin for quantification experiments were purchased
from Romer Labs at concentrations of 100 mg L−1 (pu-
rity>99.9 %) and 101 mg L−1 (purity>99.9 %), respec-
tively in ACN. Standard T2-α-Glc was prepared as des-
cribed by McCormick et al. [12]. HT2-3-O-β-Glc and
3-acetyl-T2 were enzymatically produced or chemically
synthesised within the scope of other studies (unpub-
lished data). Highly pure standards of HT2 and T2 were
used as raw materials, the final products were
characterised by nuclear magnetic resonance measure-
ments and the purities were estimated to be ≥95 %.
Stock solutions of HT2-3-O-β-Glc, 3-acetyl-T2 and
T2-α-Glc were prepared by dissolving in ACN to obtain
concentrations of 1,000, 5,000 and 2,000 mg L−1,
respectively.
Cultivation of barley plants
For the qualitative screening and the time course experiment,
barley (Hordeum vulgare L. sensu lato) variety ‘Calcule’ was
selected. This is a two-row spring barley bred by Saatzucht
Streng-Engelen GmbH & Co. KG (Germany). Seeds of the
barley variety were germinated. Pots (diameter 23 cm) were
filled with 7-L portions of a homemade substrate (mix of
500 L heat-sterilised compost, 250 L peat, 10 kg sand and
250 g rock flour). In each pot, five seedlings were planted.
The experimental design was a completely randomised block
with three biological replications (treatment of three individ-
ual barley ears per treatment group) for both plant
experiments.
During the whole experiment, the pots were watered if
required (typically three times per week). Plants for qualitative
screening were grown in the greenhouse and after tillering
transferred to a growth chamber with computer-controlled set-
tings for light, temperature and relative air humidity. Light
intensity was 560 μmol s−1 m−2 at 1 m above the soil. Relative
air humidity was set between 60 and 70 % during plant
growth. Temperature (day/night) and duration of illumination
(hours) varied according to the development stage of the
plants: after planting until the end of tillering, 12 °C/10 °C/
12 h; end tillering until mid-stem extension when the ear starts
to swell, 14 °C/10 °C/14 h; mid-stem extension to start head-
ing, 16 °C/14 °C/14 h; from the start of heading until start of
flowering, 18 °C/14 °C/14 h; and from the start of flowering
until the end of the experiments including application of the
test solutions and sampling, 20 °C/18 °C/16 h.
The time course experiment was carried out exactly as de-
scribed above with the following modifications: after tillering
the plants remained in the greenhouse with computer-
controlled settings for light, temperature and relative air hu-
midity. Light intensity was 370 μmol s−1 m−2 at 1 m above the
soil (measured after sunset).
Treatment and harvest of barley plants
Experiments included three treatment groups, HT2, T2 and
mock, which were applied separately on different barley ears
in triplicate. Treatment started at flowering stage of the respec-
tive ears. Test solutions were injected into the spikelets with an
electronic pipette. To enhance toxin diffusion into the plants,
small transparent plastic bags were internally wetted by
spraying with purified water, placed over the barley ears after
each treatment step and removed 24 h (±2 h) later. On the day
of harvest, treated barley ears were cut, weighed, immediately
frozen in liquid nitrogen and stored at −80 °C until further
processing.
Treatment for the qualitative screening experiment was
based on pipetting 5 μL of the test solution (mixture of non-
labelled and labelled toxins and mock) into spikelets of barley
ears. The lowest four spikelets per ear (two per row) were
treated, and 2, 4 and 5 days later, we continued with the next
four spikelets above. Finally, on the sixth day, two more adja-
cent spikelets were treated resulting in a total of 18 treated
spikelets or 90 μg applied toxin (native and labelled toxin).
Treated plants were harvested on the seventh day resulting in a
total of five time points per ear (treatment 7, 5, 3, 2 and 1 days
before harvest) per treatment group. One extra time point was
monitored in the form of a single treatment per treatment
group. This was performed by treating 20 spikelets (two per
row) of one ear with a total amount of 100 μg toxin and
harvesting at full-ripening stage (approx. 8 weeks after treat-
ment). Concerning all previously mentioned treatments, only
treated parts of the ears were analysed.
The following treatment procedure was used for the time
course experiments of HT2 and T2: For each toxin plus mock,
in total, 20 spikelets (two per row) were treated with 10 μL of
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the test solution (non-labelled toxins 1,000 mg L−1 and mock)
on a single day. This resulted in 200 μg applied toxin per ear.
Whole ears were sampled immediately (time point 0), 1, 3 and
7 days after treatment and at full-ripening stage (approx.
6 weeks after treatment).
Sample preparation
Frozen barley ears were milled with a ball mill (MM 301
Retsch, Haan, Germany) for 30 s at 30 Hz under cooled con-
ditions (liquid nitrogen). Milled samples were weighed (100±
2 mg) into Eppendorf tubes. Samples were extracted by
adding 500 μL ACN/H2O/FA 79+20.9+0.1 (v/v/v), vortexing
for 10 s and shaking on a rotary shaker in horizontal position
(GFL 3017, Burgwedel, Germany) at room temperature for
90 min with 200 rpm. After centrifugation for 10 min at
22,570×g, supernatants were transferred to HPLC vials. Raw
extracts of labelled samples plus mock samples were diluted
1+3 (v/v) with 0.1% aqueous FA prior to the LC-Orbitrap-MS
measurement. For each treatment group, one extract was ad-
ditionally measured undiluted as well as concentrated by a
factor of 4 (evaporated to dryness and dissolved in 1/4 vol-
ume). For structure elucidation, LC-Q-TOF-MS/MS spectra
were recorded with undiluted raw extracts of 12C/13C, as well
as 12C (time course experiment) samples. Quantification of
HT2, T2 and its metabolites was performed with 12C sample
extracts which were partially measured undiluted but also di-
luted 1+9 (v/v) and 1+49 (v/v) with ACN/H2O 1+1 (v/v).
LC-HRMS(/MS) analysis
Qualitative screening
Labelled samples and mock samples were measured with an
UltiMate 3000 HPLC system coupled to an Exactive Plus
Orbitrap mass spectrometer (both from Thermo Fisher Scien-
tific). Ten microlitres of sample solution was injected into the
system. For chromatographic separation, a Zorbax SB-C18
column (150×2.1 mm, 3.5 μm; Agilent Technologies) was
used at 25 °C and at a flow rate of 250 μL min−1. Mobile
phases consisted of H2O (eluent A) and MeOH (eluent B),
both containing 0.1 % FA (v/v) and 5 mM NH4HCO2. Gradi-
ent method 1 was as follows: 0–0.5 min, 10 % B; 0.5–
20.0 min, 10–100 % B; 20.0–25.0 min, 100 % B; 25.0–
25.1 min, 100–10 % B; and 25.1–30.0 min, 10 % B. Mass
spectrometric analysis was performed in fast polarity
switching mode using electrospray ionisation. Applied set-
tings were similar to Kluger et al. [16] with some modifica-
tions: Automatic gain control was set to 5×105, and a maxi-
mum injection time of 500 ms was used. Full scan measure-
ment was carried out in the scan range of m/z 130–1,300 with
a resolution of 70,000 full width at half maximum (FWHM) at
m/z 200. The instrument was calibrated with Pierce Ion
Calibration Solution in both polarity modes prior to analysis.
For data evaluation, software Thermo Xcalibur 2.2 was
applied.
Structure annotation and time course experiment
Further qualitative and quantitative measurements were per-
formedwith a 1290 Infinity UHPLC system coupled to a 6550
iFunnel Q-TOF mass spectrometer (Agilent Technologies).
The chromatographic method employed a Zorbax SB-C18
Rapid Resolution HD column (150×2.1 mm, 1.8 μm; Agilent
Technologies), at 30 °C and at a flow rate of 250 μL min−1.
The same mobile phase composition was used as above de-
scribed for Orbitrap measurements. For the acquisition of LC-
HRMS/MS spectra, gradient method 2 was applied: 0–
0.5 min, 10 % B; 0.5–20.0 min, 10–100 % B; 20.0–
22.0 min, 100 % B; 22.0–22.1 min, 100–10 % B; and 22.1–
25.0 min, 10 % B. To differentiate between isomers of formed
toxin metabolites in the chromatogram and to compare with
available standards, the longer gradient method 3 was used: 0–
0.5 min, 20 % B; 0.5–3.0 min, 20–45 % B; 3.0–43.0 min, 45–
65 % B; 43.0–43.1 min, 65–100 % B; 43.1–45 min, 100 % B;
45.0–45.1 min, 100–20 % B; and 45.1–50.0 min, 20 % B.
Relative and absolute quantification experiments (time course
experiments) were performed with a shortened gradient meth-
od 4: 0–0.5 min, 20 % B; 0.5–6.0 min, 20–100 % B; 6.0–
8.0 min, 100 % B; 8.0–8.1 min, 100–20 % B; and 8.1–
10.0 min, 20 % B.
LC-Q-TOF full scan mass spectra and LC-MS/MS spectra
were acquired with 2 GHz in positive and negative mode
within m/z 50–1,500 at a scan rate of 3 spectra s−1. For all
measurements, the following MS settings were used: capillary
voltage, 4,000 V; nozzle voltage, 500 V; fragmentor voltage,
380 V; drying gas temperature and flow, 130 °C and
14 L min−1, respectively; nebulizer, 30 psig; and sheath gas
temperature and flow, 300 °C and 10 L min−1, respectively.
Precursor ion selection for fragmentation occurred in the
quadrupole with an isolation width of m/z 1.3. Mass accuracy
of Q-TOF instrument was checked and potentially optimised
before analysis. Continually infused reference masses (posi-
tive m/z 121.0509, m/z 922.0098; negative m/z 112.9856, m/z
966.0007) were used for internal mass calibration during the
measurement. Data were acquired with MassHunter Acquisi-
tion software B.05.01, and data evaluation was performed
with MassHunter Qualitative and Quantitative Analysis
B.06.00.
Data processing by MetExtract
Acquired profile mode data were centroided and con-
ve r t ed to the mzXML data fo rmat [24] wi th
ProteoWizard [25] and successively processed with the
in-house developed software MetExtract [16]. The tool
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first searched for characteristic isotope patterns of native
(12C or M and M+1) and partially 13C-labelled (13C or
M′ and M′−1) metabolite ions (ion pairs) in each MS
scan. The observed m/z difference between 12C/13C me-
tabolite ion pairs corresponded to n-labelled carbon
atoms originating from the uniformly 13C-labelled tracer.
This value had to show less than ±4 ppm deviation
(based on preliminary evaluation of the mass accuracy
from raw data) from the theoretical m/z difference (Δm/
z=n×1.00335/charge). Moreover, the observed ratio of
the 12C/13C ion pairs had to be approximately 1
(±0.5). Extracted ion chromatograms (EICs, m/z extrac-
tion window of ±5 ppm) generated for M and M′ ions
were recognised as chromatographic peaks with the al-
gorithm of Du et al. [26] and had to show a minimum
Pearson correlation of 0.75. Such extracted feature pairs
were then convoluted into feature groups (i.e. metabo-
lites) using a minimum Pearson correlation of 0.9.
Method validation for quantification
For in-house method validation, apparent recovery (RA),
signal suppression or enhancement (SSE, also known as
matrix effects) and extraction recovery (RE) were deter-
mined according to Sulyok et al. [27]. Two different bar-
ley blank matrices were used for this purpose: mock time
point 1 day and mock time point ripen. A 1-mg L−1 (per
toxin) stock solution including HT2, T2, HT2-3-O-β-Glc,
3-acetyl-T2 and T2-α-Glc in ACN was prepared. Blank
samples were spiked at one level to obtain 300 μg L−1
per toxin in final matrix solution and were analysed in
biological triplicate. Apparent recovery was evaluated by
spiking stock solution before extraction to milled mock
samples. Solvent was evaporated overnight, and extraction
was conducted on the next day according to the procedure
mentioned above. Matrix effects were determined by
adding stock solution after extraction of blank mock sam-
ples to obtain 300 μg L−1 per toxin in undiluted matrix
solution as well as in 1+9 (v/v) and 1+49 (v/v) dilutions
(diluted with ACN/H2O 1+1 (v/v)). After LC-Q-TOF-MS
measurement, EICs of the target analytes ([M+NH4]
+ ad-
ducts) were automatically extracted by MassHunter Quan-
titative Analysis software with a m/z extraction window of
±30 ppm (based on preliminary evaluation of the mass
accuracy from raw data). RA and SSE were provided by
dividing the peak area of the respective metabolite obtain-
ed for spiked matrix sample by the area of a correspond-
ing standard (mean value, derived from triplicate) and
multiplying by the factor of 100. Extraction recovery
was calculated by using the ratio of RA to SSE. Mean
values and relative standard deviations (RSDs) were cal-
culated from RA, SSE and RE in triple determination.
Time course of metabolite formation—absolute
and relative quantification
Absolute and relative quantification was performed with the
UHPLC-Q-TOF instrument in positive full scan mode with
chromatographic gradient method 4 and was based on EICs
of ammonium adducts of the respective analytes (m/z extrac-
tion window of ±30 ppm). Where standards were available,
absolute amounts of HT2, T2 and its metabolites could be
plotted versus harvest time point after treatment. The follow-
ing compounds were quantified: HT2, T2, HT2-3-O-β-Glc,
3-acetyl-T2 and T2-Glc. Although the T2 metabolite T2-Glc
was annotated as T2-β-Glc, available standard T2-α-Glc was
used for quantification assuming similar ionisation efficiency.
External calibration was applied with concentrations at six
levels in the range of 3–1,000 μg L−1, and linear calibration
curves were 1/x weighted. Biological replicates and different
dilutions (mentioned above) of non-labelled samples were
analysed. Metabolite levels in respective matrices correspond-
ing to a signal-to-noise (S/N) ratio of 10 served as limit of
quantification (LOQ). Concentration values were multiplied
by ear weight to obtain results in microgram/ear or subse-
quently in micromole/ear, respectively. Based on the estimat-
ed method precision, matrix effects were only corrected if
below 85 % and above 115 %. For other biotransformation
products, relative quantification was carried out by integrating
peaks of EICs above a S/N of 3 in matrix (limit of detection,
LOD) and performing normalisation by ear weight. Thus, time
courses of normalised metabolite peak areas were graphically
displayed. Each time point value was presented as mean value
±standard deviation (n=3).
Results and discussion
The qualitative screening of HT2 and T2metabolites in barley
was generally based on treatment of barley ears with a mixture
of non-labelled and uniformly 13C-labelled toxin, extraction,
measurement of sample extracts with LC-Orbitrap-MS in fast
polarity switching mode and data processing by MetExtract.
HT2 metabolism in barley
The total ion chromatogram (TIC) and EICs based on
MetExtract data processing output of one representative la-
belled HT2 barley sample measured with LC-Orbitrap-MS is
shown in Fig. 1. After automated data processing by
MetExtract, HT2-derived metabolite peaks emerged clearly
which are presented in form of EICs.
Application of MetExtract to full scan Orbitrap-derived
chromatograms of 12C/13C-HT2 barley samples revealed fea-
tures which were grouped according to both retention time
and peak shape similarity. Every such feature group represents
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a distinct metabolite plus unmodified parent toxin HT2. Ta-
ble 1 summarises all annotated HT2metabolites in barley. The
accurate mass and ion species either of the chosen precursor
for the follow-up LC-HRMS/MS experiments or the most
abundant ion species for metabolites with low intensity are
provided. Due to methodical limitations (e.g. LOD) and the
strict criteria of MetExtract software, it is to be expected that
especially low abundant metabolites might be missed in some
samples. In most cases, this can be explained by the high
degree of 13C-isotopic enrichment of the parent toxins and
thus of its metabolites resulting in missing isotopologues
(M′−1) of the labelled metabolite form. Therefore, even
MetExtract hits detected in a single measurement only were
considered. On the other hand, MetExtract hits also included
false positives whose number increased with higher sample
concentration. These false-positive features were successfully
excluded from further data evaluation either due to an impos-
sible number of carbon atoms, implausible isotope pattern,
imperfect coelution of labelled and corresponding non-
labelled compounds or LC-HRMS/MS spectra which were
not matching any toxin fragments.
Measurements in fast polarity switching mode showed that
HT2 biotransformation products were found in both applied
polarities, and different adducts were formed which facilitated
the annotation of the molecular identity of the ion species and
increased the probability of MetExtract detection of metabo-
lites with low abundance. Mainly [M+Na]+, [M+NH4]
+ and
[M+HCOO]− adducts were formed in full scan mass spectra,
whilst for the tentative malonylglucoside (MalGlc) deriva-
tives, [M−CO2+HCOO]− adducts dominated in negative
mode. Although positive and negative adducts were mea-
sured, the HT2 metabolite 15-acetyl-T2-tetraol-Glc[–2H]
was recognised by MetExtract only in negative mode.
T2 metabolism in barley
MetExtract data evaluation of 12C/13C-T2 barley samples re-
sulted in features and feature groups. In Table 2, all
(putatively) identified T2 derivatives in barley are listed. A
comparison with Table 1 depicts that all nine toxin metabolites
detected in the HT2-treated samples were also detected in the
T2-treated samples, due to fast conversion of T2 into HT2 in
planta. For T2, four additional metabolites were detected,
namely HT2, T2-Glc, 3-acetyl-T2 and feruloyl-T2. Since
the untargeted approach enabled the detection of all HT2
metabolites in T2-treated samples, besides 15-acetyl-T2-
tetraol-Glc, 15-acetyl-T2-tetraol-MalGlc and 15-acetyl-
T2-tetraol-Glc[–2H], we manually searched for them by
extracting EICs of corresponding 12C- and 13C-mass sig-
nals. This demonstrated that the 12C/13C signal ratios dif-
fered considerably from 1 (up to 6) leading to exclusion
by MetExtract. Purity measurements of the T2 test solu-
tion showed a contamination with approximately 3 %
non-labelled neosolaniol. Thus, the enhanced 12C-mass
signal might be due to neosolaniol which had been trans-
formed into 15-acetyl-T2-tetraol and its derivatives. From
the metabolism study in wheat [13], we got a hint about
the presence of one additional T2 metabolite, namely
feruloyl-T2. Since it was not recognised by MetExtract
because of very low abundance (M′−1 isotopologue not
detected), a manual screening was performed confirming
its occurrence.
Fast polarity switching measurements showed that most T2
biotransformation products were detected in both polarities.
On the contrary, under the tested conditions, T2, T2-Glc,
3-acetyl-T2 and feruloyl-T2 were only detected in positive
mode as [M+Na]+ and [M+NH4]
+ adducts. Moreover,
T2-triol-Glc was recognised by MetExtract only in negative
ionisation mode.
Structure annotation of detected HT2 and T2 metabolites
Eachmetabolite is recorded byMetExtract with the number of
C-atoms originating from the studied HT2 or T2. Structure
Fig. 1 Illustration of fast polarity switching measurement using an
Exactive Plus Orbitrap instrument (a) and extracted ion chromatograms
(EICs) based on MetExtract data processing output (b). One
representative barley sample treated with a 1+1 (v/v) mixture of non-
labelled and uniformly 13C-labelled HT-2 toxin (5 time points per
flowering ear) was used to depict positive (orange) and negative (blue)
total ion chromatogram of Orbitrap measurement and EICs of non-
labelled (up) and labelled (down) HT-2 toxin (HT2) as well as its feature
groups (metabolites) obtained by MetExtract software. Numbers above
EICs refer to HT-2 toxin metabolites listed in Table 1, and some EICs
were scaled down for better visibility of the low abundant metabolites
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annotation was performed by searching for typical conjugates,
by calculating elemental formulas and by involving character-
istic fragments detected in HRMS/MS spectra (Table 3). All
toxin derivatives, for which LC-HRMS/MS spectra could be
obtained in positive mode, showed fragments of HT2 or T2.
The fragmentation patterns were very similar to previously re-
ported MS/MS spectra of these toxins [2, 8, 10, 11, 28]. Since
mainly Glc and MalGlc derivatives were found, typical frag-
ments of these molecules were used for metabolite characteri-
sation. Mass deviations of precursor ions did not exceed 5 ppm,
whilst mass deviations of fragments did not exceed 16 ppm.
Further LC-HRMS/MS measurements with pairs of corre-
sponding non-labelled and labelled precursor ions provided
additional information for structure annotation. By calculating
mass differences between the corresponding fragments, the
number of C-atoms remaining from the parent toxin was eluci-
dated. In contrast, according to the native isotopic composition
of the plant constituents, there was no 12C/13C mass shift for
fragments derived from glucose, malonylglucose or ferulic acid
moieties. As far as standards were available, retention time,
accurate mass and MS/MS spectra were compared for identifi-
cation of the biotransformation products. In the following part,
annotation based on LC-HRMS/MS of the individual HT2 and
T2 metabolites is described. Primarily, m/z values experimen-
tally derived from the measurements of the HT2 samples are
provided with the exception of those m/z values, which refer to
T2-specific metabolites.
15-Acetyl-T2-tetraol metabolites (metabolites 1–3)
Our data suggest that barley plants metabolised HT2 or T2 to
form putative 15-acetyl-T2-tetraol-Glc (1), 15-acetyl-T2-
tetraol-MalGlc (2) and 15-acetyl-T2-tetraol-Glc[–2H] (3) by
the cleavage of an acetyl group at C-4 position in the case of
T2, the isovaleryl group at C-8 position and covalent binding
of glucose and subsequently malonic acid. MetExtract
recognised in full scan mass spectra adducts ([1+NH4]
+, m/z
520.2380; [2+NH4]
+, m/z 606.2381; [3+HCOO]−, m/z
545.1867) with a difference of Δ17.057 u (theoretical value)
between the non-labelled and labelled metabolite form which
corresponds to remaining 17 C-atoms of the HT2 backbone,
indicating the loss of the isovaleric acid (isoval acid) moiety
minus water (containing five carbon atoms, loss of 84.058 u;
theoretical value). LC-HRMS/MS measurements of
[M+NH4]
+ and [M+HCOO]− adducts included characteristic
fragments of HT2, glucose and malonylglucose moieties as
well as fragment m/z 323.1489 (theoretical value) which cor-
responds to [15-acetyl-T2-tetraol–H2O+H]
+ (positive
LC-HRMS/MS spectra are shown in ESM Figs. S3 and S4).
Since intensities for 15-acetyl-T2-tetraol-Glc[–2H] were too
low to obtain meaningful LC-MS/MS spectra, in this case,
structure annotation was based on sum formula calculations
only. A comparison with 15-acetyl-T2-tetraol-Glc gives a dif-
ference of Δ2.014 (theoretical value) equivalent to two
H-atoms. It is assumed that after the loss of isovaleric acid
Table 1 HT-2 toxin and its (putative) biotransformation products in barley
HT2 metabolites RT (min) m/zd Iond Mass accuracy (ppm) Positive/negativee C-atomsf Sum formulag
HT2a 16.8 442.2428 [M+NH4]
+ −1.7 +/− 22 C22H32O8
1 15-Acetyl-T2-tetraol-Glcb 6.7 520.2380 [M+NH4]
+ −1.6 +/− 17 C23H34O12
2 15-Acetyl-T2-tetraol-MalGlcb 8.3 606.2381 [M+NH4]
+ −1.9 +/− 17 C26H36O15
3 15-Acetyl-T2-tetraol-Glc[–2H]c 9.2 545.1867 [M+HCOO]− −1.6 +/− 17 C23H32O12
4 Hydroxy-HT2-Glcb 12.1 620.2900 [M+NH4]
+ −2.1 +/− 22 C28H42O14
5 Hydroxy-HT2-MalGlcb 12.6 706.2906 [M+NH4]
+ −1.5 +/− 22 C31H44O17
6 T2-triol-Glcb 15.0 567.2402 [M+Na]+ −1.8 +/− 20 C26H40O12
7a HT2-di-Glcb 15.2 793.3124 [M+HCOO]− −1.5 +/− 22 C34H52O18
7b HT2-di-Glcb 15.8 793.3124 [M+HCOO]− −1.5 +/− 22 C34H52O18
8 HT2-3-O-β-Glca 16.1 604.2950 [M+NH4]
+ −2.3 +/− 22 C28H42O13
9 HT2-MalGlcb 16.1 690.2950 [M+NH4]
+ −2.6 +/− 22 C31H44O16
RT retention time, HT2 HT-2 toxin, T2 T-2 toxin, Glc glucoside, MalGlc malonylglucoside
a Confirmation with standard by comparison of retention time, accurate mass and HRMS/MS spectra
b Annotation with accurate mass, sum formula calculations and HRMS/MS spectra
c Annotation with accurate mass and sum formula calculations
d Accurate mass and ion species either of the chosen precursor for the follow-up MS/MS experiments or the most abundant ion species for metabolites
with low intensity are provided
e Detected polarity of compound either by untargeted approach or manually found
f Number of C-atoms derived from parent toxin
g Sum formula of neutral compound
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minus water, most probably a double bond (i.e. a keto group at
C-8 position) was formed.
Hydroxy-HT2 metabolites (metabolites 4 and 5)
Tentative hydroxy-HT2 metabolites were most probably
formed by hydroxylation of the isovaleryl group and conjuga-
tion of a glucose (4) and subsequently a malonic acid (5)
molecule, whilst parent toxin T2 additionally lost the acetyl




+, m/z 706.2906) were measured in full
scan mass spectra. The difference of 12C and 13C metabolite
form was Δ22.074 u (theoretical value), indicating an intact
HT2 molecule. Positive and negative LC-HRMS/MS mea-
surements of [M+NH4]
+, [M+HCOO]− and [M–H]− ions
revealed characteristic fragments of HT2, glucose and
malonylglucose moieties (positive LC-HRMS/MS spectra
are depicted in ESM Figs. S5 and S6). Furthermore, overlaid
MS/MS spectra of corresponding 12C and 13C-labelled precur-
sor ions showed that m/z 485.2003 (4) and m/z 571.2020 (5)
contain 17 C-atoms of HT2 in accordance with [M–O–isoval
acid+H]+. Additionally, in LC-HRMS/MS spectra of the neg-
ative mode (data not shown), a fragment of m/z 117.0558,
corresponding to the [M−H]− ion of isovaleric acid plus one
oxygen atom, was observed instead ofm/z 101.0608 ([M−H]−
of isovaleric acid; theoretical value) which is typical for HT2
and T2 metabolites containing an unmodified isovaleryl
group. The direct measurement of the oxygenated isovaleric
acid fragment therefore confirms that the hydroxyl group is
located at the isovaleryl group of the detected HT2 deriva-
tives. For the two metabolites of interest, the mass increments
between fragment [M–O–isoval acid+H]+ and HT2 fragment
[HT2–isoval acid+H]+ of Δ162.053 u (4) or Δ248.054 u (5)
correspond to the loss of glucose minus water or the loss of
malonylglucose minus water and verify the presence of glu-
cose (4) or malonylglucose (5), respectively.
T2-triol-Glc (metabolite 6)
Barley transformed the parent toxins by cleavage of one acetyl
group (C-15 position, in case of HT2) or two acetyl groups
(C-4 and C-15 position, in case of T2), respectively.
Table 2 T-2 toxin and its (putative) biotransformation products in barley
T2 metabolites RT (min) m/zd Iond Mass accuracy (ppm) Positive/negativee C-atomsf Sum formulag
T2a 17.9 484.2532 [M+NH4]
+ −1.9 + 24 C24H34O9
1 15-Acetyl-T2-tetraol-Glcbh 6.7 520.2384 [M+NH4]
+ −0.9 +/− 17 C23H34O12
2 15-Acetyl-T2-tetraol-MalGlcbh 8.3 606.2382 [M+NH4]
+ −1.7 +/− 17 C26H36O15
3 15-Acetyl-T2-tetraol-Glc[–2H]ch 9.3 545.1872 [M+HCOO]− −0.7 +/− 17 C23H32O12
4 Hydroxy-HT2-Glcb 12.1 620.2902 [M+NH4]
+ −1.7 +/− 22 C28H42O14
5 Hydroxy-HT2-MalGlcb 12.6 706.2912 [M+NH4]
+ −0.7 +/− 22 C31H44O17
6 T2-triol-Glcb 14.9 589.2500 [M+HCOO]− −0.3 +/− 20 C26H40O12
7a HT2-di-Glcb 15.2 793.3139 [M+HCOO]− +0.4 +/− 22 C34H52O18
7b HT2-di-Glcb 15.8 793.3139 [M+HCOO]− +0.4 +/− 22 C34H52O18
8 HT2-3-O-β-Glca 16.1 604.2953 [M+NH4]
+ −1.8 +/− 22 C28H42O13
9 HT2-MalGlcb 16.1 690.2952 [M+NH4]
+ −2.3 +/− 22 C31H44O16
10 HT2a 16.8 442.2428 [M+NH4]
+ −1.7 +/− 22 C22H32O8
11 T2-Glcc 17.0 651.2617 [M+Na]+ −1.0 + 24 C30H44O14
12 3-Acetyl-T2a 19.1 526.2640 [M+NH4]
+ −1.3 + 24 C26H36O10
13a Feruloyl-T2bh 20.0 665.2557 [M+Na]+ −1.7 + 24 C34H42O12
13b Feruloyl-T2bh 20.2 665.2551 [M+Na]+ −2.6 + 24 C34H42O12
RT retention time, HT2 HT-2 toxin, T2 T-2 toxin, Glc glucoside, MalGlc malonylglucoside
a Confirmation with standard by comparison of retention time, accurate mass and HRMS/MS spectra
b Annotation with accurate mass, sum formula calculations and HRMS/MS spectra
c Annotation with accurate mass and sum formula calculations
d Accurate mass and ion species either of the chosen precursor for the follow-up MS/MS experiments or the most abundant ion species for metabolites
with low intensity are provided
e Detected polarity of compound either by untargeted approach or manually found
f Number of C-atoms derived from parent toxin
g Sum formula of neutral compound
hNot recognised by untargeted approach
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MetExtract software recorded [6+Na]+ adduct with m/z
567.2402 and [6+HCOO]− adduct with m/z 589.2500 as well
as differences of Δ20.067 u (theoretical value) between the
12C and 13C peak pairs in LC-HRMS spectra due to a loss of
C2H2O from the parent toxin HT2. The detected fragment
[glucose–H2O–H]
− with m/z 161.0445 in negative MS/MS
spectra of adduct [M+HCOO]− led to the conclusion that
tentative T2-triol-Glc was formed.
HT2 and T2 glucosides (metabolites 7a, 7b, 8 and 11)
Glucosylation of HT2 and T2 in barley was observed, includ-
ing identified HT2-3-O-β-Glc (8) as well as putative HT2-di-
Glc (7) and T2-Glc (11) ([8+NH4]
+, m/z 604.2950;
[7+HCOO]−, m/z 793.3124; [11+Na]+, m/z 651.2617).
HT2-3-O-β-Glc and HT2-di-Glc were formed in HT2- as well
as in T2-treated (additional loss of acetyl group at C-4 posi-
tion) ears with a difference of Δ22.074 u (theoretical value)
between non-labelled and labelled metabolite forms.
LC-HRMS/MS spectra of [M+NH4]
+ (see ESM Figs. S7
and S8) and [M+HCOO]− precursor ions revealed character-
istic fragments of HT2 and glucose moieties as well as one or
two losses of glucose minus water with Δ162.053 u (theore-
tical value) calculated from [M+H]+ adducts. The observed
fragmentation patterns are consistent with the literature [2, 8,
9, 11]. Since the retention time, m/z of precursor ion and frag-
mentation pattern of the metabolite HT2-3-O-β-Glc was com-
pared with those of the HT2-3-O-β-Glc standard, the structure
could be confirmed. The application of another chromato-
graphic method with the longer gradient (gradient method 3)
showed that there was only one high metabolite peak which
eluted at the same time (15.8 min) as the standard. However,
the situation was different for HT2-di-Glc which was annotat-
ed by LC-HRMS/MS. Interestingly, two chromatographic
peaks of HT2-di-Glc were detected byMetExtract at retention
times 15.2 and 15.8 min (gradient method 1; [M+HCOO]−,
m/z 793.3124). It is assumed that HT2-di-Glc, as many other
metabolites, is derived from HT2-3-O-β-Glc by the connec-
tion of the second glucose molecule via 1,4- or 1,6-glycosidic
linkage resulting in two structural isomers. However, without
Table 3 Characteristic LC-
HRMS/MS fragment ions of
HT-2 toxin and T-2 toxin, as well
as the glucose and
malonylglucose moieties used for
structure annotation
m/za Ion Sum formulab
HT2 fragments
323.1489 [HT2 – isoval acid+H]+ C17H22O6
263.1278 [HT2 – isoval acid – acetic acid+H]+ C15H18O4









365.1595 [T2 – isoval acid+H]+ C19H24O7
305.1383 [T2 – isoval acid – acetic acid+H]+ C17H20O5
245.1172 [T2 – isoval acid – 2 acetic acid+H]+ C15H16O3





145.0495 [Glucose – 2 H2O+H]
+ C6H8O4
127.0390 [Glucose – 3 H2O+H]
+ C6H6O3
161.0455 [Glucose – H2O – H]
− C6H10O5
Malonylglucose moiety fragments
249.0605 [Malonylglucose – H2O+H]
+ C9H12O8
231.0499 [Malonylglucose – 2 H2O+H]
+ C9H10O7
145.0495 [Glucose – 2 H2O+H]
+ C6H8O4
127.0390 [Glucose – 3 H2O+H]
+ C6H6O3
105.0182 [Malonic acid+H]+ C3H4O4
161.0455 [Glucose – H2O – H]
− C6H10O5
HT2 HT-2 toxin, T2 T-2 toxin, isoval acid isovaleric acid
a Exact mass
b Sum formula of neutral compound
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nuclear magnetic resonance measurements, we cannot ex-
clude that the second glucose molecule is located at the avail-
able hydroxyl group at the C-4 position of HT2.
T2-Glc was exclusively formed in T2-treated barley. With-
in positive full scan mass spectra, MetExtract recognised dif-
ferences of Δ24.081 u (theoretical value) between the 12C and
13C peak pairs originating from an intact T2 backbone. It was
not possible to acquire a meaningful MS/MS spectrum due to
the low abundance. A retention time comparison of T2-Glc
formed in barley with standard T2-α-Glc in triplicate with the
long gradient method (gradient method 3) revealed that the
structure of metabolite T2-Glc differs from T2-α-Glc. Whilst
the biotransformation product eluted at 22.2 min, the retention
time of the standard was 21.4 min. Our findings contradict
those of McCormick et al. [12], who reported the occurrence
of T2-α-Glc in naturally contaminated oats and wheat. Since
the glucoside is most likely formed by a family 1 UDP-
glucosyltransferase, which are inverting enzymes, the forma-
tion of an alpha glucoside would be very surprising. The dif-
ference of retention times indicates that T2 is converted into
T2-3-O-β-Glc in barley under the tested conditions because
no other position of T2 is available to bind glucose. The elu-
tion order was in accordance with the mentioned study.
HT2-MalGlc (metabolite 9)
It is suggested that barley plants metabolise HT2 into HT2-3-
O-β-Glc and subsequent into tentative HT2-MalGlc by cova-
lent binding of malonic acid to the glucose moiety. Regarding
T2 metabolism, the acetyl group at C-4 position is rapidly
cleaved to form HT2 (see below). Within full scan mass spec-
tra, [9+NH4]
+ adduct withm/z 690.2950 was measured. Since
the differences of these precursor ions to its 13C-mass signals
were Δ22.074 u (theoretical value), it was obvious that the
parent toxin HT2 was intact. Figure 2 depicts the LC-MS/MS
spectrum of HT2-MalGlc in positive mode. Fragmentation of
[M+NH4]
+ and [M–H]− adducts show the typical fragments
of malonylglucose moiety plus fragment m/z 425.2170 which
corresponds to the putative loss of malonylglucose minus
water (Δ248.053 u, theoretical value) from the [M+H]+
adduct. These results compare favourably with those reported
by Kluger et al. [29], who have described a similar fragmenta-
tion pattern of deoxynivalenol-MalGlc.
HT2 as T2 metabolite (metabolite 10)
T2 was rapidly transformed into HT2 in barley by the loss of
an acetyl group at C-4 position. MetExtract detected HT2with
m/z 442.2428 [10+NH4]
+ in full scan mass spectra of
T2-treated samples. Since 22 carbon atoms were annotated
by MetExtract as well as retention time and LC-MS/MS spec-
tra were in accordance with the authentic standard, HT2 was
confirmed as T2 metabolite. LC-HRMS/MS measurement of
the [M+NH4]
+ adduct revealed typical fragments of HT2 as
listed in Table 3 (LC-MS/MS spectra of HT2 and T2 are
shown in ESM Figs. S9 and S10).
3-Acetyl-T2 (metabolite 12)
3-Acetyl-T2 was found only in T2-treated barley and was
formed by the conjugation of an acetyl group at the C-3 posi-
tion. Within positive full scan mass spectra, MetExtract
recognisedm/z 526.2640 [12+NH4]
+ adduct with a difference
of Δ24.081 u (theoretical value) between the non-labelled and
labelledmetabolite form, indicating that 3-acetyl-T2 is formed
from intact T2. Retention time, precursor ion mass and
Fig. 2 LC-HRMS/MS spectrum of HT-2 toxin-malonylglucoside (HT2-
MalGlc), an in planta metabolite of HT-2 toxin and T-2 toxin. Analysis
was performed with a 6550 iFunnel Q-TOF LC/MS system in positive
electrospray ionisation mode with a collision energy of 16 V. The
ammonium adduct was chosen as precursor (marked with a diamond).
Characteristic fragments used for annotation are highlighted, those
fragments originating from the conjugate malonylglucose are displayed
in green and characteristic HT-2 toxin fragments are marked with an
asterisk (*)
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LC-HRMS/MS spectra of the biotransformation product were
in accordance with the standard 3-acetyl-T2. The fragmenta-
tion of the [M+NH4]
+ adduct mainly generated the loss of
isovaleric acid (theoretical value, Δ102.068 u; C5H10O2),
acetic acid (theoretical value, Δ60.021 u; C2H4O2) and a
ketene (theoretical value, Δ42.011 u; C2H2O) (positive ion
mode LC-HRMS/MS spectrum is shown in ESM Fig. S11).
Feruloyl-T2 (metabolites 13a and 13b)
The presence of this metabolite suggests that ferulic acid was
covalently bound to the parent toxin T2. Since we have found
feruloyl-T2 initially in T2-treated wheat [13], we manually
extracted EICs (m/z extraction window of ±5 ppm) from
Orbitrap raw data of barley as well. Putatively identified
feruloyl-T2 is formed from intact T2 in barley because corre-
sponding EICs with a difference of Δ24.081 u ([M+Na]+, m/z
665.2568 and m/z 689.3373; theoretical values) indicated the
intact T2 toxin and showed perfect coelution as well as similar
intensities. Two distinct EIC peaks of this metabolite were
detected at retention times 20.0 and 20.2 min which might
be due to the simultaneous presence of cis- and trans-ferulic
acid conjugates of T2 toxin. Although the trans-form of
ferulic acid is the main naturally occurring one, the cis-form
might occur after light-induced non-enzymatic isomerisation
[30]. Another isomer option would result from the addition of
iso-ferulic acid instead of ferulic acid to T2. Figure 3 shows
the fragmentation pattern of this compound. In addition to
typical T2 fragments, mass signals of m/z 177.0549, m/z
145.0279 and m/z 117.0330 corresponding to [ferulic acid–
H2O+H]
+, [ferulic acid–H2O–CH3OH+H]
+ and [ferulic ac-
id – H2O–acetic acid+H]
+ were detected. Since HT2 is a
major metabolite of T2, it can be hypothesised that
ferulic acid is conjugated to the C-4 position of HT2,
whilst the C-3 position is additionally acetylated by the
plant or vice versa resulting in compounds with the
same molecular weight and putat ive ly s imi lar
LC-HRMS/MS spectra. However, with isotopic labelling
approach, we can clearly differentiate between groups
originating from plant or parent toxin. Since the T2 is
fully preserved (Δ24.081 u between 12C- and 13C-mass
signals), this hypothesis can be excluded. Thus, T2 ap-
pears to be directly and rapidly (see time course experi-
ments) metabolised by the conjugation of ferulic acid at
the C-3 position.
Screening of isomers of detected HT2 and T2 metabolites
The longer gradient method 3 was developed for LC-Q-TOF-
MS analysis to confirm the structures of HT2-3-O-β-Glc and
T2-Glc in comparison with standards. For being able to rec-
ognise additional isomers of HT2 and T2 metabolites, which
potentially had not been chromatographically separated by
LC-Orbitrap-MS analysis, method 3 was applied for the mea-
surement of labelled samples. EICs of corresponding 12C/13C
metabolite ion pairs of all detected biotransformation products
were manually extracted, overlaid and checked to confirm
coelution, similarity of elution profiles and intensities. As a
result, EICs of each of the tentative 15-acetyl-T2-tetraol-
MalGlc as well as HT2-MalGlc showed two peaks with one
major and one smaller peak (eluting 0.2 or 0.85 min earlier,
respectively, approx. 10 % intensity relative to main peak).
The observation of these isomers may result from the conju-
gation of malonic acid to different hydroxyl groups of glu-
cose. Interestingly, tentative hydroxy-HT2-Glc and hydroxy-
HT2-MalGlc which are presumably derived from HT2-3-
O-β-Glc were detected in barley in form of three isomers.
One major peak and two smaller peaks (eluting 0.15 and
0.25 min earlier, respectively, approx. 10–20 % intensity rel-
ative to major peak) were revealed, suggesting that the
Fig. 3 LC-HRMS/MS spectrum of feruloyl-T-2 toxin (feruloyl-T2), an
in planta metabolite of T-2 toxin. Analysis was performed with a 6550
iFunnel Q-TOF LC/MS system in positive electrospray ionisation mode
with a collision energy of 5 V. The ammonium adduct was chosen as
precursor (marked with a diamond). Characteristic fragments used for
annotation are highlighted, those fragments originating from the
conjugate ferulic acid are displayed in green and characteristic T-2 toxin
fragments are marked with an asterisk (*)
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additional hydroxyl group is located at different positions of
the HT2 backbone or, in case of MalGlc derivative, malonic
acid is conjugated to different hydroxyl groups of glucose.
Method validation for quantification
RA, SSE and RE were determined for HT2, T2, HT2-3-O-β-
Glc, 3-acetyl-T2 and T2-Glc. RA was very similar to SSE in
undiluted matrix solution. Therefore, calculated RE of the five
quantified compounds was between 94 and 109 % with
RSDs≤9 % (n=3). Matrix effects for 1+9 (v/v) and 1+49
(v/v) dilutions of the extraction solution were in the range of
98–114 % (RSDs≤4 %, n=3) and consequently negligible for
the intended purpose to estimate the toxin metabolism rates.
However, for undiluted samples, SSE values between 88 and
144 % (RSD≤5 %, n=3) were observed due to matrix com-
ponents which affect the ionisation process of the coeluting
metabolites of interest (see ESM Table S12).
Time courses and mass balances of HT2, T2 and its
metabolites
Time courses of quantified HT2, T2 and HT2-3-O-β-Glc
are shown in Fig. 4. It was observed that the recovery
of added HT2 and T2 at time point 0 (harvest and
quenching immediately after treatment) deviated signifi-
cantly from the expected 100 %. We presume that the
time period allowed for the toxin to diffuse into the
plant cells was too short, and thus, sample handling
for harvest and quenching resulted in a loss of toxin
solution (possible wash off of toxin by liquid nitrogen
and the contact with gloves and scissors also contribut-
ed to losses). Standard deviations for time point 0 (n=3)
were considerably higher than those of any other time
point which supports this assumption. Therefore, the
theoretically added toxin amount of 200 μg HT2 (equal
to 0.471 μmol) and T2 (0.429 μmol) at time point 0
was used as starting point to calculate percent yield of
the respective derivatives formed at later time points.
Figure 4 shows that HT2-3-O-β-Glc has been found to
be the main metabolite of both HT2 and T2 toxin which
reached its maximum already 1 day after toxin
treatment.
Kinetics of HT2 metabolism
Regarding HT2, approximately 53 % (0.250±0.054 μmol)
was transformed to HT2-3-O-β-Glc, whilst 25 % (0.116±
0.033 μmol) remained unmodified as parent toxin within
the first 24 h upon treatment. With increasing time, a
decrease of HT2 and HT2-3-O-β-Glc was observed which
ended in a content of 7 % (0.033±0.007 μmol) and 34 %
(0.161±0.034 μmol) relative to the originally added HT2
after ripening, respectively. This finding confirms that
HT2-3-O-β-Glc is further metabolised and correlates well
with the relative quantification (Fig. 5) of HT2 metabo-
lites. Taking a closer look at the formation of HT2 bio-
transformation products over time, hydroxy-HT2-Glc, hy-
droxy-HT2-MalGlc, HT2-di-Glc, HT2-MalGlc, as well as
T2-triol-Glc (detectable only at one time point) show max-
imal abundance after ripening, leading to the assumption
that they are derived from early formed HT2-3-O-β-Glc.
Moreover, 15-acetyl-T2-tetraol-Glc and 15-acetyl-T2-
tetraol-MalGlc were also found to be produced after
1 day. Although absolute quantification was not possible
for HT2-MalGlc due to the lack of an authentic standard,
comparison of EIC peak areas suggests that it belongs to
the major biotransformation products.
Kinetics of T2 metabolism
One day after treatment of barley plants with 200 μg
T2 (0.429 μmol), approximately 26 % of unmodified T2
(0.113±0.035 μmol) were still present, whilst 12 %
(0.050±0.014 μmol) had been converted into HT2 and
40 % (0.171±0.023 μmol) into HT2-3-O-β-Glc. As the
Fig. 4 Time courses of quantified HT-2 toxin (HT2, broken line), T-2
toxin (T2, continuous line) and HT-2 toxin-3-O-β-glucoside (HT2-3-O-
β-Glc, dotted line) depicted separately for HT2- (a) and T2-treated (b)
barley ears. Ears were treated with 200 μg toxin and harvested
immediately, 1, 3 and 7 days after treatment and at full-ripening stage.
For each ear, absolute analyte concentrations were measured and related
to the amount of theoretically added toxin and plotted versus harvest time
point after treatment. Analysis was performed with a 6550 iFunnel Q-
TOF LC/MS system. Error bars refer to the standard deviation of
biological triplicates
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sum of these three compounds amounts to 78 % of the
initially added T2, all other biotransformation products
of T2 made up a maximum of 22 % at this time point.
3-Acetyl-T2 was quantified with approximately 0.058 %
(0.249±0.073 nmol) of the originally added T2, whilst
T2-Glc reached a maximum of approximately 0.065 %
(0.278 nmol; only one sample at time point 1 day
showed levels>LOQ). Quantification of samples which
had been harvested 3 and 7 days after treatment showed
that the amount of T2 and HT2 had been further de-
creased, whilst the quickly formed HT2-3-O-β-Glc
remained almost constant. It is assumed that T2 is very
rapidly transformed into HT2 in planta and subsequently
converted into HT2-3-O-β-Glc being the derivative
which is then further metabolised. Time courses of rel-
ative abundance of T2 metabolites are shown in Fig. 6.
Hydroxy-HT2-Glc, hydroxy-HT2-MalGlc, T2-triol-Glc
(detectable only at one time point), HT2-di-Glc (detect-
able only at one time point) and HT2-MalGlc showed
the highest amounts after ripening, suggesting that they
are formed from HT2-3-O-β-Glc. Interestingly however,
the conjugates carrying intact T2 toxin, namely T2-Glc
(detectable only at one time point), 3-acetyl-T2 and
feruloyl-T2, all attained their maximum levels after
1 day of incubation. This observation clearly supports
the assumption that conjugation of T2 occurs immedi-
ately after application of T2 toxin, before the parent
toxin is hydrolysed to HT2.
Detoxification of HT2 and T2
It was observed that barley modifies HT2 and T2 by
using phase I as well as phase II metabolism processes.
On the one hand, hydrolysis of the non-polar acetyl and
isovaleryl groups and on the other hand hydroxylation
and covalent binding of glucose and malonic acid oc-
curred. Therefore, it is apparent that as part of the de-
toxification process, the HT2- and T2-treated plants try
to inactivate these xenobiotics by transforming them in-
to more polar compounds. Masuda et al. [31] reported
that phytotoxicity of HT2 and T2 is comparable, whilst
similar compounds without an isovaleryl group at the
C-8 position induce only minor phytotoxic effects. Since
g l u c o s y l a t i o n o f t h e t y p e B t r i c h o t h e c e n e
deoxynivalenol was confirmed to be an important detox-
ification mechanism of plants [29], it is suggested that
the glucosylated forms of HT2 and T2 are also less
phytotoxic than the parent toxins. In contrast to
Fig. 5 Relative time courses of
HT-2 toxin-derived metabolites.
Barley ears were treated with
200 μg HT-2 toxin and harvested
immediately, 1, 3 and 7 days after
treatment and at full-ripening
stage. Relative amounts (areas of
extracted ion chromatogram
peaks normalised by ear weight)
are plotted versus harvest time
point after treatment. Analysis
was performed with a 6550
iFunnel Q-TOF LC/MS system.
Error bars refer to the standard
deviation of biological triplicates.
HT2 HT-2 toxin, T2 T-2 toxin,
Glc glucoside, MalGlc
malonylglucoside
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deoxynivalenol plant metabolism, no glutathione conju-
gation was observed. A study [32] showing that tricho-
thecenes with a hydroxyl group at C-3 position are
more phytotoxic than those with an acetyl group indi-
cates that acetylation of T2 and probably conjugation of
ferulic acid at C-3 position provide an additional way
for detoxification. This is also in good agreement with
the observation that the metabolic modification at the
C-3 of HT2 and T2 is potentially dominating (shown
for conjugation of glucose to HT2). Further biological
interpretation of HT2 and T2 plant metabolism is in-
cluded in the study performed with wheat [13].
Conclusion
In this study, an analytical strategy based on isotopic
labelling, LC-Orbitrap-MS analysis in fast polarity
switching mode and data processing by MetExtract soft-
ware was used for elucidation of HT2 and T2 metabo-
lism in barley. Measurements in both electrospray polar-
ities yielded complementary information which was
shown to be highly valuable with respect to both cov-
erage as well as annotation of metabolites. The
qualitative data evaluation strategy with stable isotopic
labelling and the application of MetExtract software en-
abled the untargeted analysis by exclusive extraction of
HT2- and T2-derived biotransformation products and
supported their structure annotation by supplying
12C/13C mass shifts in MS as well as MS/MS spectra.
MetExtract provides an easy, rapid, sensitive and specif-
ic detection method. Since the Exactive Plus Orbitrap
was not equipped with a collision cell, further
MS/MS-based structure annotation experiments were
performed with a LC-Q-TOF instrument. Therefore, it
was possible to annotate and partly identify 9 HT2
and 13 T2 metabolites. The metabolism routes included
hydrolysis of acetyl and isovaleryl groups, hydroxyl-
ation as well as covalent binding of glucose, malonic
acid, acetic acid and ferulic acid. Additionally, putative
isomers of 15-acetyl-T2-tetraol-MalGlc, hydroxy-HT2-
Glc, hydroxy-HT2-MalGlc, HT2-di-Glc, HT2-MalGlc
and feruloyl-T2 (two or three isomers for each) were
revealed. As a result of the time course experiments,
HT2-3-O-β-Glc was verified as the major metabolite of
HT2 and T2 metabolism which reached its maximum
already 1 day after toxin treatment and was subsequent-
ly further metabolised.
Fig. 6 Relative time courses of
T-2 toxin-derived metabolites.
Barley ears were treated with
200 μg T-2 toxin and harvested
immediately, 1, 3 and 7 days after
treatment and at full-ripening
stage. Relative amounts (areas of
extracted ion chromatogram
peaks normalised by ear weight)
are plotted versus harvest time
point after treatment. Analysis
was performed with a 6550
iFunnel Q-TOF LC/MS system.
Error bars refer to the standard
deviation of biological triplicates.
HT2 HT-2 toxin, T2 T-2 toxin,
Glc glucoside, MalGlc
malonylglucoside
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